arrow
R

Ryu Sasaki

Nagasaki University Graduate School of Biomedical Sciences
H指数:14
被引数:924

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early Changes in Lymphocyte Counts Predict Clinical Outcomes in Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab

durvalumab联合tremelimumab治疗肝细胞癌患者淋巴细胞计数早期变化可预测临床结局

2026-10-070
OAAI
Greater Reductions in Hepatitis B Core-Related Antigen Associated with Switching from Entecavir to Tenofovir Alafenamide Compared with Continued Entecavir Therapy: A Retrospective Observational Study

与持续恩替卡韦治疗相比,从恩替卡韦转换为替诺福韦艾拉酚胺与乙型肝炎核心相关抗原更大程度的降低相关:一项回顾性观察研究

2026-05-230
OA
Long-term Outcomes of Intraductal Fully Covered Self-Expandable Metal Stents for Anastomotic Biliary Strictures After Living Donor Liver Transplantation: Clinical and Economic Evaluation

活体肝移植术后吻合口胆道狭窄长期应用完全覆膜自膨胀金属支架的临床和经济评估

2025-12-260
OAAI
Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child-Pugh Class B

阿特珠单抗联合贝伐珠单抗在Child-Pugh B级肝细胞癌患者中的有效性与安全性

2025-11-280
OAAI
Outcomes of Sequential Immune Checkpoint Inhibitor Retreatment After Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma

不可切除肝细胞癌患者接受阿特珠单抗联合贝伐珠单抗治疗后序贯免疫检查点抑制剂再治疗的结局

2025-11-010
OAAI
Association of Metabolic-Associated Steatotic Liver Disease With Clinical Outcomes of Durvalumab and Tremelimumab in Advanced Hepatocellular Carcinoma Patients: A Multicenter Study

代谢相关脂肪性肝病与度伐利尤单抗和特瑞普利单抗在晚期肝细胞癌患者临床结局中的关联:一项多中心研究

2025-08-210
PRE
Comparison Analysis of Lenvatinib Plus Transcatheter Arterial Chemoembolization Versus Atezolizumab Plus Bevacizumab as First-Line Therapy for Intermediate-Stage Hepatocellular Carcinoma Beyond the Up-to-Seven Criteria

仑伐替尼联合经导管动脉化疗栓塞与阿替利珠单抗联合贝伐珠单抗作为超出“七限”标准的中间期肝细胞癌的一线治疗比较分析

2025-05-310
PRE
The benefit of conversion therapy for patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab using newly established oncological resectability criteria in Japan
2025-02-280
PRE
Non-liver-related mortality in the DAA era: Insights from post-SVR patients with and without previous HCC history
2024-03-211
PRE
Multicenter retrospective study of stereotactic body radiotherapy for patients with previously untreated initial small hepatocellular carcinoma

未经治疗的初始小肝癌患者立体定向放疗的多中心回顾性研究

2023-04-251
PRE